BILL ANALYSIS
HR5221
NEUTRALPART Act
HR5221 (PART Act) has been assessed with a neutral outlook for investors. This legislation directly affects $GM and $STLA. The primary sectors impacted are Manufacturing and Transportation. View the full bill text on Congress.gov.
neutral
Market Sentiment
2
Affected Stocks
2
Sectors Impacted
Key Takeaways for Investors
PART Act imposes $3-$8/vehicle compliance cost on new car OEMs — immaterial to GM, F, STLA financials
Bill is early-stage (subcommittee → full committee only); no Senate companion; low probability of enactment in 2026
No direct revenue impact on any public company — this is a pure cost imposition with no offsetting winners
GM, F, and STLA recent price moves are driven by macro/tariff/earnings factors, not this bill
How HR5221 Affects the Market
For retail investors holding GM, F, or STLA, the PART Act is not a factor worth monitoring. At $3–$8/vehicle, the annual cost burden is $6M–$18M for GM, $5M–$15M for Ford, and $4M–$12M for Stellantis. Compare this to GM's $76.62 share price and $100B+ market cap, or F's $12.24 price — the impact rounds to zero. If the bill progresses to a vote (currently unlikely in 2026), expect zero price reaction. Focus on the actual drivers: tariff policy on Mexican/Canadian imports, EV tax credit extension, and the companies' Q1 2026 earnings reports due in May.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR5221 |
| Market Sentiment | neutral |
| Event Date | |
| Affected Sectors | Manufacturing, Transportation |
| Affected Stocks | $GM, $STLA |
| Source | View on Congress.gov → |
Summary
The PART Act (HR5221) imposes a minor compliance cost of $3–$8/vehicle on new car OEMs to mark catalytic converters with identifying numbers. The bill is early-stage — forwarded to full committee by voice vote in February 2026. For US-traded automakers GM, F, and STLA, the annual cost burden ($5M–$18M each) is immaterial relative to revenue and does not change competitive dynamics. No impact on stock fundamentals.